Electra Therapeutics
Health Care · Science & Engineering

Electra Therapeutics: Products & infrastructure

Electra Therapeutics has 3 clinical trials on record, 2 under way.

Data updated Nov 21, 2026 · Back to the company report

Products

Electra Therapeutics has 3 clinical trials on record, 2 under way.

3clinical trials
2trials under way
1in phase 3
2EU trials (CTIS)
EU clinical trialsthe trials it sponsors, per the EU's CTIS register
A Phase I Study to Evaluate ELA822
Human Pharmacology (Phase I)- First administration to humans · Healthy Volunteers · Austria
Aug 2026
A Phase 2/3, Open-label, Single-arm, Multicenter, Historical Control Study to Evaluate ELA026 in Participants with Seco…
Phase II and Phase III (Integrated) · Secondary Hemophagocytic Lymphohistiocytosis (sHLH) · Germany, Spain, Italy, Netherlands
Aug 2025
Clinical trialsthe studies it sponsors or works on, per ClinicalTrials.gov
A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs)
phase 1 · under way · 84 participants · T Cell Malignancies
Feb 2026
Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
phase 3 · under way · 156 participants · Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
May 2022
Evaluation of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ELA026 in Single and Multiple Doses in…
phase 1 · completed · 91 participants · Healthy Volunteers
Oct 2021
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.